COVID-19
Summing it up
Molnupiravir accounts for largest share of Covid-19 oral antiviral market, government expenditure: drug utilisation committee Molnupiravir (Lagevrio) is the most popular Covid-19 antiviral of choice, according to new data published …
‘Backorder’ for 90% of rural, remote hospital meds
The government’s response to the Covid-19 inquiry report highlighted hospital pharmacist concerns about supply chain disruption The Covid-19 Response Inquiry Report, released on Tuesday (29 October 2024) made nine recommendations …
Covid-19 response inquiry backs full scope moves
Pharmacy sector welcomes Covid-19 Response Inquiry Report’s call for action on full scope of practice The Covid-19 Response Inquiry Report is calling for nationally consistent reforms “to allow health professionals …
Covid: Has it really been so long?
It’s now been four years since the Covid-19 pandemic was declared. It has driven changes in pharmacy, as in so much of healthcare, and indeed society. Where are we currently …
Annual Covid boosters confirmed
Government accepts ATAGI recommendations for annual free Covid-19 booster shots for adults Australians aged 18 to 64 years will be eligible for annual Covid-19 jabs, Mark Butler the Minister for …
It’s 4 years since the first COVID case in Australia
Here’s how our pandemic experiences have changed over time, writes Deborah Lupton from UNSW Sydney It might be hard to believe, but four years have now passed since the first …
Anti-vaxxer abuses pharmacy staff in ‘death shot’ rant
Health workers in public hospitals have protection from abusive members of the public – but community pharmacy is left vulnerable, says a pharmacist who was recently targeted by anti-vaxxers Staff …
Tasmanian pharmacy gave expired Covid jabs
One state health department is working with a pharmacy to contact some of its patients, to whom it gave expired Covid vaccines Tasmania’s director of public health, Dr Mark Veitch, …
Covid antiviral uptake rising
Record number of Australian patients accessing antiviral treatments for Covid-19 December marked a record month for Covid antiviral use in Australia, with more than 93,000 patients receiving the medications, Chief …
No fears over antiviral supply: Butler
Health Minister says he is “not aware” of issues with supply of antivirals, despite surging case numbers, while deferring to expert advice on calls for widened PBS eligibility Speaking at …
ATAGI shifts Covid vaccine preference
Monovalent Omicron XBB.1.5 Covid-19 vaccines are now the Australian Technical Advisory Group on Immunisation’s (ATAGI’s) preferred option for individuals aged five years and older ATAGI has updated its guidance regarding …
New Covid jab approved
The TGA has approved Pfizer and BioNTech’s Omicron XBB.1.5-adapted monovalent Covid-19 vaccine Pfizer and BioNTech SE announced on Wednesday (11 October) that the Therapeutic Goods Administration has authorised their Comirnaty …